irinotecan hydrochloride trihydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial
AUST R: 167202
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection

Sponsor:
Cipla Australia Pty Ltd

Phone:
03 9696 4413

From
06 Dec 2019
to
30 Jun 2021

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
AUST R: 209857
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
30 Apr 2021
to
31 May 2021

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

DBL IRINOTECAN INJECTION 500mg/25mL irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial
AUST R: 131536
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800675229

Deletion from market:
01 Sep 2020

Shortage status:
Discontinued

Availability:
Available

Reason:
Commercial Changes / Commercial viability

DBL IRINOTECAN irinotecan hydrochloride trihydrate 40mg/2mL concentrated injection vial
AUST R: 97881
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Oct 2020

Shortage status:
Discontinued

Availability:
Available

Reason:
Other

DBL IRINOTECAN irinotecan hydrochloride100mg/5mL concentrated injection vial
AUST R: 98118
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Jul 2020

Shortage status:
Discontinued

Availability:
Available

Reason:
Other